Cluster of differentiation 4-positive and cluster of differentiation 8-positive T lymphocytes (CD4+/CD8+ T cells)

CD4-positive and CD8-positive T lymphocytes are the primary cellular components of the adaptive immune system, serving distinct yet complementary roles in host defense. CD4-positive T cells, or helper T cells, are activated by MHC class II-restricted antigens and coordinate immune responses by secreting various cytokines that influence B cell maturation and macrophage activation (StatPearls, 2023). CD8-positive T cells, or cytotoxic T cells, identify MHC class I-restricted antigens and execute the direct lysis of infected or neoplastic cells via the secretion of cytotoxic granules like perforin and granzymes (NIH, 2022). While not individual molecular targets, these cell populations are the functional focus of numerous therapeutic interventions, including immune checkpoint inhibitors like pembrolizumab and immunosuppressants like cyclosporine (PubMed, 2021). Dysregulation of these cells is central to the pathogenesis of HIV/AIDS, where CD4-positive depletion leads to immunodeficiency, and in autoimmune diseases, where aberrant T cell activation causes tissue destruction. Consequently, monitoring T cell subsets and their activation markers is essential for diagnosing immune disorders and assessing the efficacy of modern immunotherapies.

Other names

Helper T cellsCytotoxic T cellsT lymphocytesCD4+ T cellsCD8+ T cells

Therapeutic agents modulate these cells by blocking inhibitory checkpoints (e.g., PD-1/PD-L1 or CTLA-4 pathways) to enhance anti-tumor activity, or by inhibiting intracellular signaling (e.g., calcineurin inhibition) and cytokine receptors (e.g., IL-2 receptor) to suppress immune responses in transplantation and autoimmunity.